Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever

被引：0
|
作者：
Ali Şahin
Mehmet Emin Derin
Fatih Albayrak
Burak Karakaş
Yalçın Karagöz
机构：
[1] Cumhuriyet University,Department of Internal Medicine – Rheumatology, Faculty of Medicine
[2] Sivas Cumhuriyet University,Department of Biostatistic, Medical Faculty
来源：
Advances in Rheumatology | / 60卷
关键词：
Anakinra; Canakinumab; Familial Mediterranean fever (FMF); Amyloidosis; Colchicine-resistant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever
    Sahin, Ali
    Derin, Mehmet Emin
    Albayrak, Fatih
    Karakas, Burak
    Karagoz, Yalcin
    [J]. ADVANCES IN RHEUMATOLOGY, 2020, 60 (01)
  • [2] EXPERIENCE OF ANAKINRA AND CANAKINUMAB IN PATIENTS WITH COLCHICINE-RESISTANT FAMILIAL MEDITERRANEAN FEVER AND COMPLICATED WITH AMYLOIDOSIS
    Sahin, Ali
    Derin, Mehmet Emin
    Albayrak, Fatih
    Karakas, Burak
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 582 - 582
  • [3] Treatment of Colchicine-Resistant Familial Mediterranean Fever With Anakinra
    Parvaneh, Vadood Javadi
    Shiari, Reza
    [J]. ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2015, 3 (03):
  • [4] Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
    Sener, Seher
    Cam, Veysel
    Batu, Ezgi Deniz
    Kasap Cuceoglu, Muserref
    Balik, Zeynep
    Aliyev, Emil
    Bayindir, Yagmur
    Basaran, Ozge
    Bilginer, Yelda
    Ozen, Seza
    [J]. RHEUMATOLOGY, 2023, 62 (11) : 3700 - 3705
  • [5] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
    Calligaris, Lorenzo
    Marchetti, Federico
    Tommasini, Alberto
    Ventura, Alessandro
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2008, 167 (06) : 695 - 696
  • [6] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
    Lorenzo Calligaris
    Federico Marchetti
    Alberto Tommasini
    Alessandro Ventura
    [J]. European Journal of Pediatrics, 2008, 167 : 695 - 696
  • [7] The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients
    Sozeri, B.
    Sonmez, H. E.
    Karadag, S. G.
    Baglan, E.
    Ozturk, K.
    Cakan, M.
    Demir, F.
    Yener, G. Otar
    Ozdel, S.
    Ayaz, N. Aktay
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : S118 - S123
  • [8] Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever
    Laskari, Katerina
    Boura, Panagiota
    Dalekos, George N.
    Garyfallos, Alexandros
    Karokis, Dimitrios
    Pikazis, Dimitrios
    Settas, Loukas
    Skarantavos, Grigoris
    Tsitsami, Elena
    Sfikakis, Petros P.
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (01) : 102 - 109
  • [9] Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient
    Mitroulis, I.
    Papadopoulos, V. P.
    Konstantinidis, T.
    Ritis, K.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2008, 66 (11): : 489 - 491
  • [10] Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever
    Nilüfer Alpay
    Abdullah Şumnu
    Yaşar Çalışkan
    Halil Yazıcı
    Aydın Türkmen
    Ahmet Gül
    [J]. Rheumatology International, 2012, 32 : 3277 - 3279
12345